SII to seek emergency use authorisation for AstraZeneca Covid vaccine in 2 weeks: Poonawalla
Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorisation.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: AstraZeneca | Biotechnology | Clinical Trials | Emergency Medicine | Pharmaceuticals | Vaccines